DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Keck Jr P, Buffenstein A, Ferguson J et al.
Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial.
Psychopharmacology (Berl) 1998;
140: 173-184
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.